Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

By Cantarovich M.   Quantz M.   Elstein E.   Ergina P.   Magnan C.   de Varennes B.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 446-448

Elsevier

Access to resources Recommend Favorite

Rabbit antithymocyte globulin induction immunosuppression in heart transplantation

By Chien N.C.   Lin F.L.   Chou N.K.   Hsu R.B.   Wang S.S.   Chu S.H.   Ko W.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2380-2382

Elsevier

Access to resources Recommend Favorite

Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center

By Lavee J.   Bar-Zohar D.   Har-Zahav Y.   Freimark D.   Casif Y.   Shinfeld A.   Smolinsky A.K.  

Transplantation Proceedings, Vol. 32, Iss. 4, 2000-06 ,pp. : 737-739

Elsevier

Access to resources Recommend Favorite

Effect of antithymocyte globulin induction treatment on renal transplant outcome

By Sanchez-Fructuoso A.I.   Naranjo P.   Torrente J.   Fernandez-Perez C.   Aviles B.   Prats D.   Barrientos A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1790-1792

Elsevier

Access to resources Recommend Favorite

Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients

By Abou-Jaoude M.M.   Ghantous I.   Najm R.   Afif C.   Almawi W.Y.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2731-2732

Elsevier

Access to resources Recommend Favorite